Alx Oncology Holdings Inc (ALXO)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.00
- As of
Kresmion compiles this page from ALXO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
ALX ONCOLOGY HOLDINGS INC (ALXO): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-16.
See the full ALXO dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for ALXO on one page. Preview it with sample data, then open it live with a free account.
Preview the ALXO dossierActive events for ALXO
- mediumEarnings above estimates
Q2-2026: Beat consensus by 11.1%, EPS $-0.13 vs $-0.1462 estimate
- mediumEarnings above estimates
Q2-2025: Beat consensus by 6.3% - EPS $-0.43 vs $-0.459 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 9.6% - EPS $-0.41 vs $-0.374 estimate
- mediumEarnings above estimates
Beat consensus by 6.3% - EPS $-0.43 vs $-0.459 estimate
- mediumEarnings below estimates
Missed consensus by 9.6% - EPS $-0.41 vs $-0.374 estimate
FREE, NO ACCOUNT
Every event on ALXO, as it fires
You are seeing 5 of 6 events recorded on ALXO since 2026-05-26.
The five above landed across 3 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
ALXO positions held by the managers we follow (2026Q3)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP 00166B105 · 2026Q3 | $638K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ALXO
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
More data on ALXO
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in ALXO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ALXO in the last 180 days.
Upstream: SEC EDGAR filings for ALXO
Kresmion, "ALX ONCOLOGY HOLDINGS INC (ALXO) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/ALXO. Upstream data: SEC EDGAR filings for ALXO.
Link to this data (HTML):
<a href="https://kresmion.com/research/ALXO">ALX ONCOLOGY HOLDINGS INC (ALXO) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow ALXO on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ALXO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.